Clinical outcome of long-term lamivudine treated chronic HBV infected and HIV/HBV coinfected patients.
Elefsiniotis
Ioannis S
IS
Paparizos
V
V
Dourakis
S P
SP
Mpotsi
C
C
Pantazis
K D
KD
Katsambas
N
N
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine